about
Sepsis and ARDS: The Dark Side of HistonesPrognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis.Improving Selection Criteria for ALK Inhibitor Therapy in Non-Small Cell Lung Cancer: A Pooled-Data Analysis on Diagnostic Operating Characteristics of Immunohistochemistry.Adoptive Immunotherapy in Postoperative Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.White light, autofluorescence and narrow-band imaging bronchoscopy for diagnosing airway pre-cancerous and early cancer lesions: a systematic review and meta-analysis.Always hard to absorb: youngsters suicide from childhood adversity.Evaluation bias in objective response rate and disease control rate between blinded independent central review and local assessment: a study-level pooled analysis of phase III randomized control trials in the past seven years.Updated statistics of lung and bronchus cancer in United States (2018).[Propensity Score Matching Analysis of VATS Lobectomy and Sublobar Resection for Stage I Lung Adenocarcinoma].Systematic bias between blinded independent central review and local assessment: literature review and analyses of 76 phase III randomised controlled trials in 45 688 patients with advanced solid tumourErratum to updated statistics of lung and bronchus cancer in United States (2018)The prognostic value of metformin for advanced non-small cell lung cancer: a systematic review and meta-analysisHIV and tuberculosis co-infection in East Asia and the Pacific from 1990 to 2017: results from the Global Burden of Disease Study 2017Endpoint surrogacy in oncological randomized controlled trials with immunotherapies: a systematic review of trial-level and arm-level meta-analysesAssociation of binge drinking in adolescence and early adulthood with high blood pressure: findings from the National Longitudinal Study of Adolescent to Adult Health (1994-2008)Tubeless video-assisted thoracic surgery for lung cancer: is it ready for prime time?Endpoint surrogacy in oncology Phase 3 randomised controlled trials
P50
Q27027282-79AC7AA7-1B01-4E5F-B127-C807C27EFF63Q31034428-06336CAE-7EEE-4123-949A-29C36BC496D2Q31041155-CF364F85-FD22-4B8B-A91D-868D44C22F80Q36129903-8E49E110-D7B2-42D5-9A2D-1B758C536761Q37528212-92CFD432-DAFB-4C03-8B42-C56569964CA1Q47135438-5CB66B5F-94CA-4958-9638-D97B40381275Q47141744-B631715A-0104-48D9-81D4-878C3E1E46C1Q55343134-547CAF9D-C48D-4E47-8579-9AA754087758Q55446899-139C3F70-1590-4F4A-A5FD-BB55F5A26415Q58753938-10DBFFD0-7A2C-48FC-B0CA-21876F55BE9FQ64081046-25DBCEEB-EAF0-48C3-8852-C10883F88BF1Q90541158-94520FE9-442B-45DD-9B80-4B836AA920D5Q90963420-44F8CA11-2155-4F4D-8A8F-1C9692F469ADQ91975883-1653C50F-6988-4893-81C5-F698F3F1456BQ93010558-5AC32EED-C8EC-4050-A871-12D0F0F2F5EAQ94605318-4D968ABF-CD99-46A4-B100-5C22D07456BFQ95832238-9D667B10-F303-4A85-9FB8-4965F45484D7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jianrong Zhang
@ast
Jianrong Zhang
@en
Jianrong Zhang
@es
Jianrong Zhang
@nl
Jianrong Zhang
@sl
type
label
Jianrong Zhang
@ast
Jianrong Zhang
@en
Jianrong Zhang
@es
Jianrong Zhang
@nl
Jianrong Zhang
@sl
prefLabel
Jianrong Zhang
@ast
Jianrong Zhang
@en
Jianrong Zhang
@es
Jianrong Zhang
@nl
Jianrong Zhang
@sl
P106
P1153
56964550800
P31
P496
0000-0003-4688-5222